Movement Alert｜10x Genomics, Inc. Rises 5.05% in Regular Trading, Optimistic Earnings Preview and Multi-Institution Collaborations Catalyze Rally

Market Focus07-31

On July 31, 10x Genomics, Inc. rose 5.05% in regular trading, trading at $48.66/share, with turnover of $50.66 million.

On the news front, the company is set to report quarterly earnings on August 6 after market close, with consensus estimates projecting revenue of approximately $147 million, representing 5.28% year-over-year growth, while adjusted EPS is expected at -$0.24, a 34.45% improvement from the prior year. Additionally, the company recently established collaborations with Lausanne University Hospital and Cleveland Clinic to advance single-cell and spatial technology applications in cancer diagnostics, and completed its acquisition of Proteintech Genomics to expand proteomics capabilities.

BofA Securities raised its price target significantly from $30 to $46 in July, with overall analyst sentiment rated overweight. The prior quarter saw strong results with EPS of -$0.10 beating estimates of -$0.30 by 66.67%, while revenue of $150.8 million also exceeded expectations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108558474?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 01:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108558474","market":"hk","top_or_hot":-1,"title":"Movement Alert｜10x Genomics, Inc. Rises 5.05% in Regular Trading, Optimistic Earnings Preview and Multi-Institution Collaborations Catalyze Rally","media":"Market Focus","content":"<p><p>On July 31, 10x Genomics, Inc. rose 5.05% in regular trading, trading at $48.66/share, with turnover of $50.66 million.</p><p>On the news front, the company is set to report quarterly earnings on August 6 after market close, with consensus estimates projecting revenue of approximately $147 million, representing 5.28% year-over-year growth, while adjusted EPS is expected at -$0.24, a 34.45% improvement from the prior year. Additionally, the company recently established collaborations with Lausanne University Hospital and Cleveland Clinic to advance single-cell and spatial technology applications in cancer diagnostics, and completed its acquisition of Proteintech Genomics to expand proteomics capabilities.</p><p>BofA Securities raised its price target significantly from $30 to $46 in July, with overall analyst sentiment rated overweight. The prior quarter saw strong results with EPS of -$0.10 beating estimates of -$0.30 by 66.67%, while revenue of $150.8 million also exceeded expectations.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜10x Genomics, Inc. Rises 5.05% in Regular Trading, Optimistic Earnings Preview and Multi-Institution Collaborations Catalyze Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜10x Genomics, Inc. Rises 5.05% in Regular Trading, Optimistic Earnings Preview and Multi-Institution Collaborations Catalyze Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-31 01:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 31, 10x Genomics, Inc. rose 5.05% in regular trading, trading at $48.66/share, with turnover of $50.66 million.</p><p>On the news front, the company is set to report quarterly earnings on August 6 after market close, with consensus estimates projecting revenue of approximately $147 million, representing 5.28% year-over-year growth, while adjusted EPS is expected at -$0.24, a 34.45% improvement from the prior year. Additionally, the company recently established collaborations with Lausanne University Hospital and Cleveland Clinic to advance single-cell and spatial technology applications in cancer diagnostics, and completed its acquisition of Proteintech Genomics to expand proteomics capabilities.</p><p>BofA Securities raised its price target significantly from $30 to $46 in July, with overall analyst sentiment rated overweight. The prior quarter saw strong results with EPS of -$0.10 beating estimates of -$0.30 by 66.67%, while revenue of $150.8 million also exceeded expectations.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TXG","symbol_name":"10x Genomics, Inc.","start_time":0,"source_url":"","article_id":"1108558474","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108558474","pubTimestamp":1785430904,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 31, 10x Genomics, Inc. rose 5.05% in regular trading, trading at $48.66/share, with turnover of $50.66 million.On the news front, the company is set to report quarterly earnings on August 6...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TXG":"10x Genomics, Inc."},"translate_title":"走势警报|10x Genomics, Inc. 常规交易上涨 5.05%，乐观的盈利预览和多机构合作催化反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":1},"content_text":"On July 31, 10x Genomics, Inc. rose 5.05% in regular trading, trading at $48.66/share, with turnover of $50.66 million.On the news front, the company is set to report quarterly earnings on August 6 after market close, with consensus estimates projecting revenue of approximately $147 million, representing 5.28% year-over-year growth, while adjusted EPS is expected at -$0.24, a 34.45% improvement from the prior year. Additionally, the company recently established collaborations with Lausanne University Hospital and Cleveland Clinic to advance single-cell and spatial technology applications in cancer diagnostics, and completed its acquisition of Proteintech Genomics to expand proteomics capabilities.BofA Securities raised its price target significantly from $30 to $46 in July, with overall analyst sentiment rated overweight. The prior quarter saw strong results with EPS of -$0.10 beating estimates of -$0.30 by 66.67%, while revenue of $150.8 million also exceeded expectations.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"preview","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108558474","isCrawlerRequest":true}